The effect of aliphatic esters on the formation and degradation behavior of PLGA-based in situ forming system

Polymer Bulletin

Volumn 66, Issue 8, 2011, Pages 1063-1073

  Mashak, A ^a   Mobedi, H ^a   Ziaee, F ^a   Nekoomanesh, M ^a  

^a IRAN POLYMER AND PETROCHEMICAL INSTITUTE   (Iran)

Author keywords

Aliphatic esters; Biodegradation; In situ forming systems; Morphology; Poly (lactide co glcolide); Solvent removal

Indexed keywords

ALIPHATIC ESTERS; CONTROL MATRICES; DEGRADATION BEHAVIOR; DEGRADATION RATE; ESTER ADDITIVES; IN SITU FORMING SYSTEMS; IN-SITU FORMING; IN-VITRO; MORPHOLOGICAL ANALYSIS; PHASE INVERSION; PHOSPHATE BUFFER SOLUTIONS; POLY (LACTIDE-CO-GLCOLIDE); POLY-LACTIDE-CO-GLYCOLIDE; POLYMER DEGRADATION; POROUS STRUCTURES; SOLVENT REMOVAL;

BIODEGRADATION; DEGRADATION; ESTERIFICATION; IONIC LIQUIDS; MOLECULAR WEIGHT; MORPHOLOGY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PHOTODEGRADATION;

ESTERS;

EID: 79958132622     PISSN: 01700839     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00289-010-0386-7     Document Type: Article

References (25)

1. E Ruel-Gariepy JC Leroux 2004 In situ-forming hydrogels-review of temperature-sensitive systems Eur J Pharm Biopharm 58 409 426 10.1016/j.ejpb.2004.03.019 1:CAS:528:DC%2BD2cXmsVGnsL8%3D (Pubitemid 39037244)
2. R Bakhshi E Vasheghani-Farahani H Mobedi A Jamshidi M Khakpour 2006 The effect of additives on naltrexone hydrochloride release and solvent removal rate from an injectable in situ forming PLGA implant Polym Adv Technol 17 354 359 10.1002/pat.717 1:CAS:528:DC%2BD28XnsVaktb8%3D (Pubitemid 44044486)
3. R Astaneh M Erfan J Barzin H Mobedi HR Moghimi 2008 Effects of ethyl benzoate on performance, morphology, and erosion of PLGA implants formed in situ Adv Polym Technol 27 17 26 10.1002/adv.20114 1:CAS:528:DC%2BD1cXhsFaiu73K
4. A Hatefi B Amsden 2002 Biodegradable injectable in situ forming drug delivery systems J Control Release 80 9 28 10.1016/S0168-3659(02)00008-1 1:CAS:528:DC%2BD38XisFyrs7s%3D (Pubitemid 34273745)
5. H Kranz R Bodmeier 2007 A novel in situ forming drug delivery system for controlled parenteral drug delivery Int J Pharm 332 107 114 10.1016/j.ijpharm. 2006.09.033 1:CAS:528:DC%2BD2sXhvVSlu7w%3D (Pubitemid 46227772)
6. M Korber R Bodmeier 2008 Development of an in situ forming PLGA drug delivery system: I. Characterization of a non-aqueous protein precipitation Eur J Pharm Sci 35 283 292 10.1016/j.ejps.2008.07.007
7. Dunn RL, English JP, Cowsar DR, Vanderbelt DP (1990) Biodegradable in situ forming implants and methods of producing the same. US Patent 4,938,763
8. J Siepmann A Gopferich 2001 Mathematical modeling of bioerodible, polymeric drug delivery systems Adv Drug Deliv Rev 48 229 247 10.1016/S0169-409X(01)00116-8 1:CAS:528:DC%2BD3MXjtlaqs7w%3D (Pubitemid 32434405)
9. ML Houchin EM Topp 2008 Chemical degradation of peptides and proteins in PLGA: a review of reactions and mechanisms J Pharm Sci 97 2395 2404 10.1002/jps.21176 1:CAS:528:DC%2BD1cXotF2mur4%3D
10. Chandrashekar BL, Zhou M, Jarr EM, Dunn RL (2000) Controlled release liquid delivery compositions with low initial drug burst. US Patent 6,143,314
11. RA Jain CT Rhodes AM Railkar AW Malick NA Shah 2000 Controlled release of drugs from injectable in situ formed biodegradable PLGA microspheres: effect of various formulation variables Eur J Pharm Biopharm 50 257 262 10.1016/S0939-6411(00)00062-X 1:CAS:528:DC%2BD3cXlvFWhtr8%3D
12. H Mobedi M Nekoomanesh H Orafaei H Mivehchi 2006 Studying the degradation of poly(l-lactide) in presence of magnesium hydroxide Iran Polym J 15 31 39 1:CAS:528:DC%2BD28XjtFegs7w%3D
13. ML Houchin SA Neuenswander EM Topp 2006 Effect of excipients on PLGA film degradation and on the stability of an incorporated peptide J Control Release 117 413 420 10.1016/j.jconrel.2006.11.023 (Pubitemid 46216583)
14. M Ara M Watanabe Y Imai 2002 Effect of blending calcium compounds on hydrolytic degradation of poly (dl-lactic acid-co-glycolic acid) Biomaterials 23 2479 2483 10.1016/S0142-9612(01)00382-9 1:CAS:528:DC%2BD38XivVShsL0%3D (Pubitemid 34288489)
15. SJ Siegel JB Kahn, et al. 2006 Effect of drug type on the degradation rate of PLGA matrices Eur J Pharm Biopharm 64 287 293 10.1016/j.ejpb.2006.06.009 1:CAS:528:DC%2BD28XhtFSrur3M (Pubitemid 44585214)
16. M Takenaga Y Yamaguchi, et al. 2002 A novel sustained-release formulation of insulin with dramatic reduction in initial rapid release J Control Release 79 81 91 10.1016/S0168-3659(01)00518-1 1:CAS:528:DC%2BD38XhtlSls7g%3D (Pubitemid 34164163)
17. Dunn RL, Tipton AJ (1997) Polymeric compositions useful as controlled release implants. US Patent 5,702,716
18. M Zare H Mobedi, et al. 2008 Effect of additives on release profile of leuprolide acetate in an in situ forming controlled release system: in vitro study J Appl Polym Sci 107 3781 3787 10.1002/app.27520 1:CAS:528: DC%2BD1cXhvVSkur0%3D (Pubitemid 351388247)
19. AJ McHugh 2005 The role of polymer membrane formation in sustained release drug delivery systems J Control Release 109 211 221 10.1016/j.jconrel. 2005.09.038 1:CAS:528:DC%2BD2MXht12jt7nI (Pubitemid 41737265)
20. KJ Brodbeck S Pushpala AJ McHugh 1999 Sustained release of human growth hormone from PLGA solution depots Pharm Res 16 1825 1829 10.1023/A:1018943107688 1:CAS:528:DC%2BD3cXkt1egtw%3D%3D (Pubitemid 30040697)
21. PD Graham KJ Brodbeck AJ McHugh 1999 Phase inversion dynamics of PLGA solutions related to drug delivery J Control Release 58 233 245 10.1016/S0168-3659(98)00158-8 1:CAS:528:DyaK1MXhsVentL8%3D (Pubitemid 29112894)
22. Hawley's Condensed Chemical Dictionary (11th edn). Van Nostrand Reinhold Co., NY, NY, pp 224, 555, 567
23. G Schwach N Oudry S Delhomme M Luck H Lindner R Gurny 2003 Biodegradable microparticles for sustained release of a new GnRH antagonist. Part I: screening commercial PLGA and formulation technologies Eur J Pharm Biopharm 56 327 336 10.1016/S0939-6411(03)00096-1 1:CAS:528:DC%2BD3sXos12qtbs%3D (Pubitemid 37346505)
24. http://www.boehringer.com/. www.resomer.com. Boehringer Ingelheim Pharma GmbH & Co. KG. Accessed 20 Oct 2009
25. X Zhang UP Wyss D Pichora MFA Goosen 1994 Investigation of poly(lactic acid) degradation J Bioact Compat Polym 9 80 100 10.1177/088391159400900105 1:CAS:528:DyaK2cXjtVOhsLg%3D